NCT01897571 2024-03-26Study of Tazemetostat as Single Agent in Solid Tumors or B-cell Lymphomas and in Combination With Prednisolone in DLBCLIpsenPhase 1/2 Completed400 enrolled 22 charts 1 FDA
NCT00379574 2013-03-15Bortezomib Plus CHOP Every 2 Weeks for Advanced Stage DLBCLAsan Medical CenterPhase 1/2 Completed49 enrolled 8 charts